Bind Therapeutics is a Noncommercial Biotechnical Research business in Cambridge, MA.
| Company Name: | Bind Therapeutics |
| Company Classification: | Noncommercial Biotechnical Research |
| Company Location: | 325 Vassar St, Cambridge, MA 02139 |
| Telephone Number: | (617) 491-3400 |
| Company Representative: | Scott Minick, Chief Executive Officer |
| Company Url: | bindtherapeutics.com |
| NAICS Number: | 4461100 |
| SIC Number: | 8733 |
| Market Factor: | B2B (Business to Business) |
| Begining Year: | 2006 |
| Employee Amount: | 1 to 4 |
| Location Category: | Single Location |
| Annual Earning (USD): | $5.000.000 to $9.999.999 |
| Share This Business: | |
| Related Businesses: |
Transkaryotic Therapies Inc - Middlesex, MA Massachusetts Institute Of Technology - Middlesex, MA Genewiz - Middlesex, MA |
Bind Therapeutics is a company that has been operational since 2006, offering products or services in the industry of Noncommercial Biotechnical Research. For additional details of the nature of this business, it is registered under with the SIC code 8733 and under the NAICS code 4461100 ().
Bind Therapeutics now supports a growing employee population of 1 to 4 and the business makes an estimated annual revenue of $5.000.000 to $9.999.999. The company can be reached for inquiries about B2B market variables and other concerns by contacting Scott Minick, Chief Executive Officer by phone (617) 491-3400.
For added convenience and more information, Bind Therapeutics also has a website at bindtherapeutics.com, and can be accessed and followed through the social media outlets Twitter and Facebook . Visit Bind Therapeutics’s physical single location at 325 Vassar St, Middlesex, Massachusetts or locate it via the coordinates 42.35488,-71.1056.